Table 4 % Drug activity of different formulations (Mean ± SD)
From: Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis
Group no. | Formulation | % Orthokeratosis | % Drug activity |
|---|---|---|---|
1 | Normal saline | 44 ± 1.05% | 0 |
2 | TQ suspension | 51.73.2 ± 2.15% | 17.1 ± 1.03% |
3 | Nigella sativa extract | 50.56 ± 3.01% | 13 ± 1.25% |
4 | TQ loaded EV Gel | 55.23 ± 2.05% | 25 ± 2.35% |
5 | Tazarotene™ | 51.17 ± 2.03% | 19.2 ± 1.05% |